Abstract
In the 1980s, the number of cases of syphilis in the United States increased concurrently with the onset of the HIV epidemic. Within a short time, clinicians began to note unusual presentations of syphilis and inappropriate responses to standard therapy for syphilis in dually infected patients. Whether these cases collectively represented a new aspect of the natural history of syphilis remains to be elucidated. In recent years, only a few prospective studies have addressed this issue, and the results of these studies have been inconclusive.
Similar content being viewed by others
References and Recommended Reading
Kreiss J, Coombs R, Plummer F, et al.: Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989, 160:380–384.
Telzak E, Chiasson M, Bevie P, et al.: HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med 1993, 119:1181–1185.
Greenblatt R, Lukehart S, Plummer F, et al.: Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 1988, 2:47–50.
Plummer F, Wainberg M, Plourde P, et al.: Detection of human immunodeficiency virus type-1 in genital ulcer exudate of HIV-1 infected men by culture and gene amplification [letter]. J Infect Dis 1990, 161:810.
Grosskurth H, Mosha F, Todd J, et al.: Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995, 346:530–536.
Rolfs R, Joesoef R, Hendershot E, et al.: Early syphilis treatment: a randomized trial of enhanced therapy in HIV infected and uninfected persons. N Engl J Med 1997, 337:307–314. s is the only large-scale, prospective trial to study therapy for early-stage syphilis since the beginning of the AIDS epidemic.
Hutchinson C, Hook E, Sheperd M, et al.: Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 1994, 121:94–99.
Shulkin D, Tripoli L, Abell E: Lues maligna in a patient with human immunodeficiency virus infection. Am J Med 1988, 85:425–427.
Radolf J, Kaplan R: Unusual manifestations of secondary syphilis and abnormal humoral immune response to Treponema pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol 1988, 18:423–428.
Gourevitch M, Selwyn P, Davenny D, et al.: Effects of HIV infection on the serologic manifestation and response to treatment of syphilis in intravenous drug users. Ann Intern Med 1993, 118:350–355.
Rompalo A, Cannon R, Quinn T, et al.: Association of biologic false positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis 1992, 165:1124–1126.
Augenbraun M, Dehovitz J, Feldman J, et al.: Biological falsepositive syphilis test results for women infected with human immunodeficiency virus. Clin Infect Dis 1994, 19:1040–1044.
Hicks C, Benson P, Lupton G: Seronegative secondary syphilis in a patient infected with human immunodeficiency virus with Kaposi’s sarcoma. Ann Intern Med 1987, 107:492–495.
Johnson P, Graves S, Stewart L, et al.: Specific syphilis serological tests may become negative in HIV infection. AIDS 1991, 5:419–423.
Augenbraun M, Rolfs R, Johnson R, et al.: Treponemal specific tests for the serodiagnosis of syphilis. Sex Transm Dis 1998, 25:549–552. Treponemal serologic tests (ie, fluoresecent treponemal antibody absorption or microhemagglutination assay-T. pallidum) may frequently become nonreactive after therapy.
Centers for Disease Control and Prevention: 1998 guidelines for the treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998, 47(RR-1):1–116. This is a concise, straightforward, authoritative summation of treatment for sexually transmitted diseases.
Telzak E, Greenberg M, Harrison J, et al.: Syphilis treatment response in HIV-infected individuals. AIDS 1991, 5:591–595.
Moorthy T, Lee C, Lim K, Tan T: Ceftriaxone for the treatment of primary syphilis in men: a preliminary study. Sex Transm Dis 1987, 14:116–118.
Hook E, Roddy R, Handsfield H: Ceftriaxone for incubating and early syphilis. J Infect Dis 1988, 158:881–884.
Augenbraun M, Workowski K: Ceftriaxone therapy for syphilis: report from the Emerging Infections Network. Clin Infect Dis 1999, 29:1337–1338.
Verdon M, Handsfield H, Johnson R: Pilot study of azithromycin for the treatment of primary and secondary syphilis. Clin Infect Dis 1994, 19:486–488.
Lukehart S, Fohn M, Baker-Zander S: Efficacy of azithromycin for therapy of active syphilis in the rabbit model. J Antimicrob Chemother 1990, 25(suppl A):91–99.
Hook E, Stephans J, Ennis D: Azithromycin compared with benzathine penicillin for the treatment of incubating syphilis. Ann Intern Med 1999, 131:434–437.
Malone J, Wallace M, Hendrick B, et al.: Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med 1995, 99:55–63.
Yinnon A, Coury-Doniger P, Polito R, Reichman R: Serologic response to treatment of syphilis with HIV infection. Arch Intern Med 1996, 156:321–325.
Goeman J, Kivuvu M, Nzila N, et al.: Similar serologic response to conventional therapy for syphilis among HIV-positive and HIV-negative women. Genitourin Med 1995, 71:275–279.
Lukehart S, Hook E, Baker-Zander S, et al.: Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988, 109:855–862.
Berry C, Hooten T, Collier A, et al.: Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987, 316:1587–1589.
Johns D, Tierney M, Felsenstein D: Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987, 316:1569–1572.
Swartz M: Neurosyphilis. In Sexually Transmitted Diseases. Edited by Holmes K, Mardh P, Sparling P, Wiesner P. New York: McGraw-Hill; 1990:231–246.
Hollander H: Cerebrospinal fluid normalities and abnormalities in individuals infected with human immunodeficiency virus. J Infect Dis 1988, 158:855–858.
Marra C, Gary D, Kuppers J, Jacobson M: Diagnosis of neurosyphilis in patients infected with human immunodeficiency virus type 1. J Infect Dis 1996, 174:219–221.
Moore J, Hopkins H: Asymptomatic neurosyphilis: VI. Arch Derm Syph 1930, 95:1637–1641.
Augenbraun M, Chiu C: Rates of neurosyphilis in out-patients undergoing lumbar puncture [abstract]. In Proceedings of the 13th Meeting of the International Society for Sexually Transmitted Diseases Research. Denver, 1999:86.
Marra C, Boutin P, McArthur J, et al.: A pilot randomized trial evaluating ceftriaxone and penicillin G as therapies for neurosyphilis in HIV-ACTG 145. Neurology 1999, 52:A193.
Gordon S, Eaton M, George R, et al.: The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994, 331:1469–1473.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Augenbraun, M. The diagnosis and management of syphilis in the HIV-infected patient. Curr Infect Dis Rep 2, 10–13 (2000). https://doi.org/10.1007/s11908-000-0081-1
Issue Date:
DOI: https://doi.org/10.1007/s11908-000-0081-1